Johnson & Johnson vaccine

  1. Johnson & Johnson vaccine: CDC lifts suspension amid blood clot concerns

    Advisers to the CDC voted 10-4 to resume the shot’s emergency use authorization in the U.S. for everyone 18 and older. The panel said Friday that the vaccine’s benefits outweigh that serious but small risk — especially against a virus that’s still infecting tens of thousands of Americans every day.

    Region:
    USA
    Category:
    Society
    Johnson & Johnson vaccine: CDC lifts suspension amid blood clot concerns
  2. Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect

    The EU's drugs regulator has said that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson Covid-19 vaccine.
    The European Medicines Agency (EMA) on Tuesday recommended a warning should be added to the vaccine’s product information, but stressed that the benefits of the shot – which was put on hold last week in Europe and the US – outweighed its risks.

    Region:
    Europe
    Category:
    Society
    Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect